WO2024115998 - AN IN VITRO METHOD FOR ASSESSING THE RISK THAT A SUBJECT SUFFERS FROM CANCER
National phase entry is expected:
Publication Number
WO/2024/115998
Publication Date
06.06.2024
International Application No.
PCT/IB2023/061410
International Filing Date
11.11.2023
Title **
[English]
AN IN VITRO METHOD FOR ASSESSING THE RISK THAT A SUBJECT SUFFERS FROM CANCER
[French]
MÉTHODE IN VITRO D'ÉVALUATION DU RISQUE DE CANCER CHEZ UN SUJET
Applicants **
PADZA-PADTAN-PAJHOOH
Inventors
RABBANI, Hodjattallah
SADEGHI, Niloufar
MOHAMMADI, Javad
Priority Data
140150140003006424
01.12.2022
IR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1958 | |
| EPO | Filing, Examination, Granting | 11551 | |
| Japan | Filing, Examination, Granting | 2000 | |
| South Korea | Filing, Examination, Granting | 1802 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,051
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention is related to an in vitro method for assessing the risk that a subject suffers from a cancer. The invention also provides a method for detecting of cells in a test tissue sample from the subject that express Nanog on the cell membrane including breast, liver, lung, bladder, and cervical cancer and any cancer cell expressing the membrane isoform of Nanog.[French]
La présente invention concerne une méthode in vitro d'évaluation du risque de cancer chez un sujet. L'invention concerne également une méthode de détection de cellules dans un échantillon test de tissu provenant du sujet qui expriment Nanog sur la membrane cellulaire comprenant le cancer du sein, du foie, du poumon, de la vessie et du col de l'utérus et toute cellule cancéreuse exprimant l'isoforme membranaire de Nanog.